Connect with us

Hi, what are you looking for?

Friday, Apr 19, 2024
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.

Industry update

Canadian pot production slows as supply eases to 1.1B grams

Around 96,000 kg of dried bud was produced last December, an 11-month low, as cultivators grapple with supply issues

Canadian pot production slows as supply glut eases to 1.1 billion grams
Canadian pot production slows as supply glut eases to 1.1 billion grams

Canadian pot producers significantly cut production in December, as the country’s mountain of inventory shrunk slightly from an all-time high.

The total volume of unsold dried cannabis inventory held by federal licence holders, provincial distributors and retailers in December was 1,141,000 kilograms, according to new data from Health Canada. Total inventory eased from 1,166,000 kilograms a month prior.

The nationwide supply glut has forced some of the biggest outdoor and indoor growers in the country to significantly cut production in the last year.

Canadian pot production slows as supply glut eases to 1.1 billion grams

Unpackaged dried flower production and inventory held by Canadian licensed cannabis producers. Chart via Health Canada

Around 96,000 kilograms of dried weed were produced last December, the lowest monthly total since January 2020 when less than 89,000 kilograms were produced.

When a record number of outdoor crops were being harvested last October, a peak of 220,461 kilograms of dried cannabis was added to the already oversupplied market.

At the start of last year’s planting season in June, Health Canada had licensed 1,200 acres of outdoor growing area, almost triple the 450 acres approved in 2019.

As of December, the federal agency had issued licences for a record 1,551 acres of open-air cultivation.

The surge in outdoor supply only added to the glut of largely unsellable mid-tier bud, which has spurred scale-backs of outdoor and indoor production operations.

Last month, Ontario-based 48North Cannabis Corp. (TSXV: NRTH) pulled the plug on its outdoor cultivation operations in Brant County, citing a significant transition period for the industry.

In 2020, mega-producer Canopy Growth Corp. (TSX: WEED) (Nasdaq: CGC) closed several large indoor facilities and axed around 1,000 workers.

The oversupplied market has also catalyzed a wave of consolidation.

This month, Canopy bought rival producer The Supreme Cannabis Company (TSX: FIRE) for $435 million.

Canadian pot production slows as supply glut eases to 1.1 billion grams

Cannabis flower drying at a 48North facility in Brant County, Ontario. Press photo

The Ontario company hopes its tie-up with Supreme will give it a 13.6-per-cent share of the recreational market.

After Canopy enjoyed a quarter of the adult-use market in mid-2019, the firm’s lead has slipped as competitors gained in strength and number over the past year.

As more smaller players come into the market, heavyweights like Canopy are being forced to focus on producing quality over quantity.

Total licensed indoor and greenhouse area in December fell to a one-year low of 18.7-million square feet, Health Canada’s latest figures show. The monthly data also provides inventory and sales figures for extracts and edible cannabis products.

Medical and recreational sales of extract products like vapes, oils and capsules reached a record 1.8 million packaged units sold in December.

But almost 11.6 million extract products were being held in inventory in the same month by producers, retailers and distributors.

Total extract-based recreational sales reached $329.9 million in 2020, according to Statistic Canada’s retail commodity survey.

Edible sales in the medical and adult-use market reached a record of almost 2.3 million packages sold in December. However, monthly inventory numbers for edible packages hit an all-time high of 15.2 million.

Total edible sales in the Canadian adult-use market reached $109.2 million in 2020, according to StatsCan.

Top image via Organigram

 

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Follow Jared Gnam on Twitter

jared@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Cannabis

Company forced to reevaluate as government entity reclassifies cannabis products

Psychedelics

The treatment provider is a joint venture between ATMA Journey Centers and Cena Life

Psychedelics

Kelsi Sheren said that other treatment methods for her PTSD and depression were ineffective

Cannabis

The research will be funded by the GIRAFF program which will offer $1.84 million in total to eight projects in the agriculture and aquaculture...